返回搜索

Acute myeloid leukemia

KEGG ID: hsa05221

中文名称

急性髓系白血病

通路描述

急性髓系白血病(AML)是一种由克隆性增殖的未受控细胞和骨髓中原始细胞积累的疾病,伴有分化程序受损。AML 约占所有成人白血病的 80%,仍然是导致白血病死亡的最常见原因。两种主要的遗传事件已被描述,对于白血病转化至关重要。提出的必要第一个事件是细胞生长紊乱和细胞生存基因的上调。最常见的这些激活事件发生在 RTK Flt3、N-Ras 和 K-Ras、Kit 以及其他 RTK 中。调节造血分化的髓系转录因子中的改变是白血病发生的第二个必要事件。转录因子融合蛋白,如 AML-ETO、PML-RARα或 PLZF-RARα,通过抑制靶基因来抑制髓系细胞分化。在其他情况下,转录因子本身发生突变。
英文描述
Acute myeloid leukemia (AML) is a disease that is characterized by uncontrolled proliferation of clonal neoplastic cells and accumulation in the bone marrow of blasts with an impaired differentiation program. AML accounts for approximately 80% of all adult leukemias and remains the most common cause of leukemia death. Two major types of genetic events have been described that are crucial for leukemic transformation. A proposed necessary first event is disordered cell growth and upregulation of cell survival genes. The most common of these activating events were observed in the RTK Flt3, in N-Ras and K-Ras, in Kit, and sporadically in other RTKs. Alterations in myeloid transcription factors governing hematopoietic differentiation provide second necessary event for leukemogenesis. Transcription factor fusion proteins such as AML-ETO, PML-RARalpha or PLZF-RARalpha block myeloid cell differentiation by repressing target genes. In other cases, the transcription factors themselves are mutated.

所含基因

68 个基因